
Alliance Pharma, the highly-acquisitive speciality pharmaceutical company, has around £22m on tap to add to its growing portfolio of branded medicines and treatments, it said this week. The undrawn funds are available in its bank facility, the Chippenham-based firm announced in a pre-close trading update to the London Stock Exchange ahead of its interim...